Cystic fibrosis is a common genetic disease caused by mutations in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR), a Cl-channel with novel properties. Knowledge of the structure and function of CFTR remains superficial. The main goal of this research is to better understand how CFTR forms a Cl-channel with a specific focus on the membrane spanning domains (MSDs) and their interaction with the rest of the protein.
Specific Aim 1 focuses on understanding how the MSDs contribute to the formation of the channel pore by addressing several questions. 1) How do different amino acid sequences in Xenopus and human CFTR generate differences in function? The development and study of chimeric proteins will identify regions and specific residues that confer the unique properties associated with CFTR. 2) Do proline residues in the MSDs contribute to the formation of the channel pore? Proline has unique properties that are predicted to confer a bend in the helices forming the channel. By studying the effect of replacing these prolines an assessment of channel structure will be obtained. 3) Which residues line the channel pore? Blockers that irreversibly interact with introduced cysteines will identify residues that line the pore. 4) How do membrane- spanning sequences associate to form the channel? The studies will use a biochemical approach to test the hypothesis that transmembrane sequences in CFTR contain explicit structural information that causes them to form specific interactions.
Specific Aim 2 focuses on the role that the intracellular loops (ICLs) play in controlling function and in protein:protein interactions. 1) Do intracellular loops determine the conduction or regulatory properties of CFTR Cl-channels? The patch-clamp technique will be used to test how changes in the ICLs affect channel function with particular emphasis given to ICLs that contain clusters of CF mutations. 2) Do intracellular loops interact with cytosolic domains? The work will test the hypothesis that direct physical interactions exist between the ICLs and the cytoplasmic regulatory domains. The results will provide new insights into the structure and function of CFTR and the way that CF-associated mutations disrupt function. The results will also increase understanding of the structure of other medically important ABC transporters and may give new insight into the construction of ion channels.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37HL029851-17
Application #
6017214
Study Section
Physiology Study Section (PHY)
Project Start
1986-07-01
Project End
2000-05-31
Budget Start
1999-09-01
Budget End
2000-05-31
Support Year
17
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Iowa
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
041294109
City
Iowa City
State
IA
Country
United States
Zip Code
52242
Randak, Christoph O; Welsh, Michael J (2005) ADP inhibits function of the ABC transporter cystic fibrosis transmembrane conductance regulator via its adenylate kinase activity. Proc Natl Acad Sci U S A 102:2216-20
Randak, Christoph O; Welsh, Michael J (2005) Adenylate kinase activity in ABC transporters. J Biol Chem 280:34385-8
Berger, Allan L; Randak, Christoph O; Ostedgaard, Lynda S et al. (2005) Curcumin stimulates cystic fibrosis transmembrane conductance regulator Cl- channel activity. J Biol Chem 280:5221-6
Berger, Allan L; Ikuma, Mutsuhiro; Welsh, Michael J (2005) Normal gating of CFTR requires ATP binding to both nucleotide-binding domains and hydrolysis at the second nucleotide-binding domain. Proc Natl Acad Sci U S A 102:455-60
Randak, Christoph; Welsh, Michael J (2003) An intrinsic adenylate kinase activity regulates gating of the ABC transporter CFTR. Cell 115:837-50
Liu, Lei; Leonard, A Soren; Motto, David G et al. (2003) Contribution of Drosophila DEG/ENaC genes to salt taste. Neuron 39:133-46
Berger, Allan L; Ikuma, Mutsuhiro; Hunt, John F et al. (2002) Mutations that change the position of the putative gamma-phosphate linker in the nucleotide binding domains of CFTR alter channel gating. J Biol Chem 277:2125-31
Hennager, D J; Ikuma, M; Hoshi, T et al. (2001) A conditional probability analysis of cystic fibrosis transmembrane conductance regulator gating indicates that ATP has multiple effects during the gating cycle. Proc Natl Acad Sci U S A 98:3594-9
Cotten, J F; Welsh, M J (1999) Cystic fibrosis-associated mutations at arginine 347 alter the pore architecture of CFTR. Evidence for disruption of a salt bridge. J Biol Chem 274:5429-35
Hall, R A; Ostedgaard, L S; Premont, R T et al. (1998) A C-terminal motif found in the beta2-adrenergic receptor, P2Y1 receptor and cystic fibrosis transmembrane conductance regulator determines binding to the Na+/H+ exchanger regulatory factor family of PDZ proteins. Proc Natl Acad Sci U S A 95:8496-501

Showing the most recent 10 out of 45 publications